Pneuma Respiratory Appoints Brian Thomas as Project Manager and Kade McNaughton as Controller

BOONE, N.C., July 23, 2018 /PRNewswire/ -- Pneuma Respiratory, Inc. (Pneuma), which has developed PNEUMAHALER™, the first breath-activated digital inhaler (BDI), has hired Brian Thomas as Project Manager and Kade McNaughton as Controller.

Brian brings extensive product research and development experience to the Project Manager role at Pneuma Respiratory. He has held senior science and technology positions with Stryker Corporation and Zimmer Biomet. "I am excited to work with the talented team at Pneuma on the development and commercialization of the Pneumahaler," stated Mr. Thomas. "We are extremely fortunate to have someone with Brian's background and experience join the organization," said Eric Hunter, CEO and Founder of Pneuma Respiratory.

Brian Thomas has a B.S. in Chemistry and a Ph.D. in Inorganic Chemistry from Clemson University as well as an M.B.A. from Indiana University.

Kade McNaughton brings in excess of twenty years of financial experience to the Controller position. She has directly handled all aspects of accounting and financial analysis responsibilities for a wide variety of clients as a consultant as well as in corporate roles with Arthur Andersen and Lowe's Companies. "I am looking forward to the entrepreneurial opportunity with Pneuma Respiratory," stated Ms. McNaughton. "Kade's extensive financial experience will be incredibly valuable as we grow our organization," said Rich Gimigliano, CFO of Pneuma Respiratory.

Kade McNaughton has a B.S. in Accounting from the University of Nevada, Las Vegas and an M.S. in Psychology from Chestnut Hill College. She also is the holder of a CPA license.

About Pneuma Respiratory

Launched in 2015, Pneuma Respiratory is a pharmaceutical company based in Boone, North Carolina. With a global team of researchers, physicians, designers and engineers, Pneuma has created PNEUMAHALER™, the first fully integrated digital breath activated inhaler.  The inhaled delivery system has integrated Bluetooth technology to provide feedback on drug delivery to patients, family members and health care providers. Using Pneuma's [proprietary/patented] digital droplet ejector technology, Pneuma's  device, although currently available for investigational purposes only, has the potential to ultimately deliver a spectrum of novel therapies, including biologics, through the lungs. For more information visit www.pneumarespiratory.com.

Contact:
Eric Hunter
8284346433
[email protected]

SOURCE Pneuma Respiratory

Related Links

http://www.pneumarespiratory.com